Senti Biosciences Q4 EPS $(0.53) Misses $(0.48) Estimate, Sales $22.000K Miss $666.667K Estimate

Senti Biosciences (NASDAQ: SNTI) reported a Q4 loss of $(0.53) per share, missing the analyst estimate of $(0.48) by 11.11%. This represents an improvement from a loss of $(0.67) per share in the same quarter last year. The company's quarterly sales were $22,000, significantly below the expected $666,667, missing estimates by 96.70%.